Short Interest in Procaps Group S.A. (NASDAQ:PROC) Increases By 455.1%

Procaps Group S.A. (NASDAQ:PROC) saw a significant growth in short interest in November. As of November 15th, there was short interest totalling 113,800 shares, a growth of 455.1% from the October 31st total of 20,500 shares. Approximately 0.6% of the company’s stock are short sold. Based on an average trading volume of 68,700 shares, the short-interest ratio is currently 1.7 days.

Procaps Group Stock Up 53.7 %

Shares of Procaps Group stock traded up $0.73 during trading hours on Thursday, hitting $2.09. 211,740 shares of the company’s stock traded hands, compared to its average volume of 30,771. The stock has a 50 day simple moving average of $1.72 and a 200-day simple moving average of $2.14. Procaps Group has a twelve month low of $0.50 and a twelve month high of $4.95.

About Procaps Group

Procaps Group SA develops, produces, and markets pharmaceutical solutions worldwide. The company formulates, manufactures, and markets branded prescription drugs in various therapeutic areas, including feminine care products, pain relief, skin care, digestive health, growth and development, cardiology, vision care, central nervous system, and respiratory.